The Latest Breaking News from Jazz

The biotech industry is well-positioned to grow strongly, given the ever-rising demand for therapies and favorable government initiatives. Looking at the industry’s long-term prospects, fundamentally strong biotech stocks Amgen (AMGN), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) could emerge as big winners this year. Keep reading….

Jazz at Thunder: How to watch, lineups, injury reports and broadcast for Friday.

Milwaukee has continued its surge without Giannis Antetokounmpo. Plus, the Mavericks and Heat slide.

Quin Synder was an assistant on Mike Budenholzer’s Hawks staff back when the basketball program had a clear vision. You knew what those Hawks were about.

Atlanta moved quickly to replace Nate McMillan, as they’ve agreed to terms with the former Jazz coach.

Quin Snyder is the next head coach of the Hawks, the team announced Sunday night. He will be introduced at a news conference on Monday.

The best photos from the Thunder's 120-119 OT loss to the Jazz on Thursday.

Player grades for the Thunder's 120-119 OT loss to the Jazz.

Who will be taking home the hardware at season’s end?

Thunder at Jazz: How to watch, lineups, injury reports and broadcast for Thursday.

While higher rates have hurt growth stocks last year, 2023 could be the year of growth stocks gaining momentum. Amid rising optimism, investors could consider buying fundamentally strong growth stocks Gilead Sciences (GILD), Jazz (JAZZ), and Masonite International (DOOR) this year. Keep reading.